(Q48252158)

10 February 2018

title

A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine (English)

1 reference

10 February 2018

author name string

Rachel L Gross

1

1 reference

10 February 2018

Jason Brucker

2

1 reference

10 February 2018

Asena Bahce-Altuntas

3

1 reference

10 February 2018

Maria A Abadi

4

1 reference

10 February 2018

Jules Lipoff

5

1 reference

10 February 2018

David Kotlyar

6

1 reference

10 February 2018

Peter Barland

7

1 reference

10 February 2018

Chaim Putterman

8

1 reference

10 February 2018

publication date

25 June 2011

1 reference

10 February 2018

published in

Clinical Rheumatology

1 reference

10 February 2018

volume

30

1 reference

10 February 2018

issue

10

1 reference

10 February 2018

page(s)

1385-1392

1 reference

10 February 2018

Cocaine use and its rheumatic manifestations: a case report and discussion.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole-induced cutaneous necrosis mimicking coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole, the story and the lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Treatment of rheumatoid arthritis with levamisole. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

On the biochemical mode of action of levamisole: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole: A Dangerous New Cocaine Adulterant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

A boy with cutaneous necrosis occurring during treatment with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Cutaneous necrotising vasculitis induced by levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Cocaine abuse: dermatologic manifestations and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Cocaine-induced pseudovasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Neutropenia during treatment of rheumatoid arthritis with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

High frequency of agranulocytosis in breast-cancer patients treated with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Cases: Cocaine adulterant linked to neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Agranulocytosis after consumption of cocaine adulterated with levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Detection of anticardiolipin antibody in patients with cocaine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1805-3

Treatment of nephrotic syndrome with levamisole

21 January 2018

1 reference

12 December 2020

Levamisole-induced retiform purpura

1 reference

12 December 2020

Agranulocytosis, levamisole, and HLA-B27

1 reference

12 December 2020

Levamisole and neutropenia

1 reference

12 December 2020

Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies

1 reference

12 December 2020

Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children

1 reference

12 December 2020

Retiform purpura: a new stigmata of illicit drug use?

1 reference

12 December 2020

Treatment of seronegative spondylarthritis with levamisole: A double-blind placebo-controlled study

1 reference

12 December 2020

Agranulocytosis associated with cocaine use - four States, March 2008-November 2009

1 reference

12 December 2020

Levamisole and agranulocytosis

1 reference

12 December 2020

Reversible retiform purpura: a sign of cocaine use

1 reference

12 December 2020

PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse

1 reference

12 December 2020

10.1007/S10067-011-1805-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018